Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy

医学 队列 逻辑回归 接收机工作特性 观察研究 内科学 随机森林 强的松 机器学习 计算机科学
作者
Xiaolan Mo,Xiujuan Chen,Huasong Zeng,Wei Zheng,Chifong Ieong,Huixian Li,Qiongbo Huang,Zichuan Xu,Jinlian Yang,Qianying Liang,Huiying Liang,Xia Gao,Min Huang,Jiali Li
出处
期刊:Pharmacotherapy [Wiley]
卷期号:43 (1): 43-52 被引量:7
标识
DOI:10.1002/phar.2749
摘要

STUDY OBJECTIVE: The pharmacokinetics and pharmacodynamics of tacrolimus (TAC) vary greatly among individuals, hindering its precise utilization. Moreover, effective models for the early prediction of TAC efficacy in patients with nephrotic syndrome (NS) are lacking. We aimed to identify key factors affecting TAC efficacy and develop efficacy prediction models for childhood NS using machine learning algorithms. DESIGN: This was an observational cohort study of patients with pediatric refractory NS. SETTING: Guangzhou Women and Children's Medical Center between June 2013 and December 2018. PATIENTS: 203 patients with pediatric refractory NS were used for model generation and 35 patients were used for model validation. INTERVENTION: All patients regularly received double immunosuppressive therapy comprising TAC and low-dose prednisone or methylprednisolone. In this observational cohort study of 203 pediatric patients with refractory NS, clinical and genetic variables, including single-nucleotide polymorphism (SNPs), were identified. TAC efficacy was evaluated 3 months after administration according to two different evaluation criteria: response or non-response (Group 1) and complete remission, partial remission, or non-remission (Group 2). MEASUREMENTS: Logistic regression, extremely random trees, gradient boosting decision trees, random forest, and extreme gradient boosting algorithms were used to develop and validate the models. Prediction models were validated among a cohort of 35 patients with NS. MAIN RESULTS: The random forest models performed best in both groups, and the area under the receiver operating characteristics curve of these two models was 80.7% (Group 1) and 80.3% (Group 2). These prediction models included urine erythrocyte count before administration, steroid types, and eight SNPs (ITGB4 rs2290460, TRPC6 rs3824934, CTGF rs9399005, IL13 rs20541, NFKBIA rs8904, NFKBIA rs8016947, MAP3K11 rs7946115, and SMARCAL1 rs11886806). CONCLUSIONS: Two pre-administration models with good predictive performance for TAC response of patients with NS were developed and validated using machine learning algorithms. These accurate models could assist clinicians in predicting TAC efficacy in pediatric patients with NS before utilization to avoid treatment failure or adverse effects.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhudaxia完成签到,获得积分10
1秒前
1秒前
1秒前
花痴的手套完成签到 ,获得积分10
1秒前
麦粑块发布了新的文献求助10
2秒前
小牛牛发布了新的文献求助10
2秒前
2秒前
4秒前
INT发布了新的文献求助10
5秒前
hyy发布了新的文献求助30
5秒前
研友_VZG7GZ的应助被李瑞程采纳,获得10
5秒前
小蘑菇的应助被醉熏的寄松采纳,获得10
6秒前
我是谁的应助被醉熏的寄松采纳,获得50
6秒前
zhudaxia发布了新的文献求助30
6秒前
领导范儿的应助被醉熏的寄松采纳,获得10
6秒前
慕青的应助被醉熏的寄松采纳,获得10
6秒前
无花果的应助被醉熏的寄松采纳,获得10
6秒前
Lucas的应助被醉熏的寄松采纳,获得10
6秒前
国服躺赢完成签到,获得积分10
6秒前
搜集达人的应助被醉熏的寄松采纳,获得10
7秒前
7秒前
桐桐的应助被醉熏的寄松采纳,获得30
7秒前
7秒前
7秒前
陈富贵完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
growl发布了新的文献求助10
8秒前
任亮亮发布了新的文献求助10
9秒前
逆光完成签到,获得积分10
9秒前
gg完成签到,获得积分10
9秒前
领导范儿的应助被韩明佐采纳,获得10
11秒前
科研通AI6.4的应助被zack采纳,获得10
11秒前
端庄书雁发布了新的文献求助10
12秒前
Orange的应助被chenchen采纳,获得10
12秒前
其7发布了新的文献求助10
13秒前
我是老大的应助被无心的大叔采纳,获得10
13秒前
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183263
求助须知:如何正确求助?哪些是违规求助? 9572532
关于积分的说明 21826339
捐赠科研通 7780187
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558131
邀请新用户注册赠送积分活动 2480239